In addition to supporting a wide range of research studies, the HIMC is actively engaged in several research and development projects to optimize new technology platforms and develop and novel immune monitoring assays. We are always interested in new technology and welcome partnerships with industry collaborators to evaluate and develop new immune monitoring platforms. We have already engaged in several completed and ongoing research collaborations with companies including Fluidigm, Biolegend, eBioscience, Cytognos, Innova Biosciences, Glass Expansion, Curiox BioSystems,10X Genomics and CyTek. If you are interested in technology collaboration, please contact Seugnhee Kim-Schulze, our facility director.

In addition to academic studies, the HIMC has extensive experience with supporting immune monitoring studies sponsored by several industry collaborators including Celgene, BMS, Janssen, Pfizer, Takeda, Immune Design, Gradalis, TapImmune, AstraZeneca, Genetec, and DynaVax.

Contact Us